|
Patient Info
Information for Patients
Physicians are advised to discuss the following issues with patients for whom they prescribe PAXIL: Drugs That Interfere With Hemostasis (NSAIDs, Aspirin, Warfarin, etc.): Patients should be cautioned about the concomitant use of PAXIL and nonsteroidal anti-inflammatory drugs, aspirin, or other drugs that affect coagulation since combined use of these drug products has been associated with an increased risk of bleeding.
Interference With Cognitive and Motor Performance: Any psychoactive drug may impair judgment, thinking, or motor skills. Although in controlled studies PAXIL has not been shown to impair psychomotor performance, patients should be cautioned about operating hazardous machinery, including automobiles, until they are reasonably certain that therapy with PAXIL does not affect their ability to engage in such activities.
Completing Course of Therapy: While patients may notice improvement with treatment with PAXIL in 1 to 4 weeks, they should be advised to continue therapy as directed. Text Continues Below
Concomitant Medication Patients should be advised to inform their physician if they are taking, or plan to take, any prescription or over-the-counter drugs, since there is a potential for interactions. Alcohol Although PAXIL has not been shown to increase the impairment of mental and motor skills caused by alcohol, patients should be advised to avoid alcohol while taking PAXIL. Pregnancy Patients should be advised to notify their physician if they become pregnant or intend to become pregnant during therapy. Nursing: Patients should be advised to notify their physician if they are breast-feeding an infant (see PRECAUTIONS— Nursing Mothers). Laboratory Tests There are no specific laboratory tests recommended.
|
.gif)
